Centogene NV has a consensus price target of $7.17, established from looking at the 10 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on June 28, 2023, May 18, 2023, and April 27, 2023. With an average price target of $1.83 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 154.28% upside for Centogene NV from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
06/28/2023 | CNTG | Buy Now | Centogene | $0.72 | 108.04% | HC Wainwright & Co. | Yi Chen | → $1.5 | Reiterates | Buy → Buy | Get Alert |
05/18/2023 | CNTG | Buy Now | Centogene | $0.72 | 108.04% | HC Wainwright & Co. | Yi Chen | $2.5 → $1.5 | Maintains | Buy | Get Alert |
04/27/2023 | CNTG | Buy Now | Centogene | $0.72 | 246.74% | HC Wainwright & Co. | Yi Chen | → $2.5 | Reiterates | → Buy | Get Alert |
04/13/2023 | CNTG | Buy Now | Centogene | $0.72 | 246.74% | HC Wainwright & Co. | Yi Chen | → $2.5 | Reiterates | → Buy | Get Alert |
04/12/2023 | CNTG | Buy Now | Centogene | $0.72 | 246.74% | HC Wainwright & Co. | Yi Chen | → $2.5 | Reiterates | → Buy | Get Alert |
02/22/2023 | CNTG | Buy Now | Centogene | $0.72 | 246.74% | HC Wainwright & Co. | Yi Chen | → $2.5 | Reiterates | → Buy | Get Alert |
01/17/2023 | CNTG | Buy Now | Centogene | $0.72 | 246.74% | HC Wainwright & Co. | Yi Chen | → $2.5 | Reiterates | → Buy | Get Alert |
11/23/2022 | CNTG | Buy Now | Centogene | $0.72 | 246.74% | HC Wainwright & Co. | Yi Chen | → $2.5 | Initiates | → Buy | Get Alert |
07/18/2022 | CNTG | Buy Now | Centogene | $0.72 | 732.18% | SVB Leerink | Puneet Souda | $10 → $6 | Maintains | Outperform | Get Alert |
06/17/2021 | CNTG | Buy Now | Centogene | $0.72 | 1841.75% | Credit Suisse | Erin Wright | — | Maintains | Outperform | Get Alert |
The latest price target for Centogene (NASDAQ: CNTG) was reported by HC Wainwright & Co. on June 28, 2023. The analyst firm set a price target for $1.50 expecting CNTG to rise to within 12 months (a possible 108.04% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Centogene (NASDAQ: CNTG) was provided by HC Wainwright & Co., and Centogene reiterated their buy rating.
There is no last upgrade for Centogene.
There is no last downgrade for Centogene.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Centogene, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Centogene was filed on June 28, 2023 so you should expect the next rating to be made available sometime around June 28, 2024.
While ratings are subjective and will change, the latest Centogene (CNTG) rating was a reiterated with a price target of $0.00 to $1.50. The current price Centogene (CNTG) is trading at is $0.72, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.